Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
2008

Targeting PDGF Signaling in Cervical Cancer

Sample size: 90 publication 10 minutes Evidence: high

Author Information

Author(s): Pietras Kristian, Pahler Jessica, Bergers Gabriele, Hanahan Douglas

Primary Institution: University of California San Francisco

Hypothesis

Pharmacological targeting of stromal support functions, particularly those of cancer-associated fibroblasts, could have therapeutic utility in cervical cancer.

Conclusion

Targeting PDGF receptor signaling in cancer-associated fibroblasts can slow the progression of cervical cancer and impair tumor growth.

Supporting Evidence

  • Imatinib treatment reduced the incidence of cervical carcinomas from 80% to 47%.
  • Median tumor volume decreased by 61% following imatinib treatment.
  • Imatinib treatment lowered the cell proliferation index and increased the apoptotic index in tumors.

Takeaway

Researchers found that blocking a specific signal in tumor-supporting cells can help slow down cervical cancer in mice.

Methodology

The study used a genetically engineered mouse model of cervical cancer to investigate the effects of PDGF receptor signaling inhibition using imatinib.

Limitations

The study was conducted in a mouse model, which may not fully replicate human cervical cancer.

Participant Demographics

HPV/E2 mice, a genetically engineered mouse model.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pmed.0050019

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication